Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary

Rohan A Elliott1, Michael C Woodward, C Alice Oborne

  • 1Centre for Applied Gerontology, Bundoora Extended Care Centre, Bundoora VIC 3083, Australia. rohan.elliott@armc.org.au

Age and Ageing
|September 21, 2002
PubMed

Insights

Antithrombotic therapy for atrial fibrillation in older patients was under-prescribed. Audit and feedback improved prescribing, particularly aspirin, though warfarin remained under-used.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Pharmacology

Background:

  • Atrial fibrillation is prevalent in elderly populations, increasing ischemic stroke risk.
  • Antithrombotic therapy is underutilized despite its proven efficacy in stroke prevention.

Purpose of the Study:

  • To audit antithrombotic prescribing in elderly inpatients with atrial fibrillation using an evidence-based indicator.
  • To evaluate the impact of multidisciplinary feedback on antithrombotic prescribing rates.

Main Methods:

  • Cross-sectional notes-based audits were conducted before and after feedback.
  • Data collected from 1416 inpatients aged 65+ across nine Australian hospitals.
  • Appropriateness defined as receiving warfarin/aspirin or having contraindications.

Main Results:

  • Appropriate antithrombotic prescribing increased significantly from 72% to 92% post-feedback (P<0.0001).
  • Aspirin prescribing saw the most substantial improvement; warfarin remained under-prescribed.
  • Prescribing appropriateness slightly decreased at 6 months but remained elevated.

Conclusions:

  • Older patients with atrial fibrillation are frequently under-prescribed antithrombotics.
  • Audit and multidisciplinary feedback effectively improved antithrombotic use.
  • The intervention demonstrated a greater impact on aspirin compared to warfarin prescribing.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...